Australian Clinical Labs Limited (ASX:ACL)
2.820
+0.030 (1.08%)
At close: Dec 5, 2025
Australian Clinical Labs Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2017 |
| Market Capitalization | 545 | 540 | 503 | 694 | 922 | 686 | Upgrade
|
| Market Cap Growth | -21.82% | 7.36% | -27.51% | -24.69% | 34.33% | - | Upgrade
|
| Enterprise Value | 814 | 834 | 805 | 1,001 | 1,160 | 940 | Upgrade
|
| Last Close Price | 2.82 | 2.69 | 2.34 | 3.09 | 3.70 | 2.67 | Upgrade
|
| PE Ratio | 16.54 | 16.66 | 21.03 | 19.34 | 5.17 | 11.37 | Upgrade
|
| Forward PE | 14.98 | 13.94 | 13.83 | 15.92 | 9.64 | 7.42 | Upgrade
|
| PS Ratio | 0.74 | 0.73 | 0.72 | 1.00 | 0.93 | 1.06 | Upgrade
|
| PB Ratio | 3.17 | 3.14 | 2.83 | 4.02 | 3.96 | 8.38 | Upgrade
|
| P/TBV Ratio | 88.68 | 87.92 | 39.99 | 95.82 | 13.75 | - | Upgrade
|
| P/FCF Ratio | 3.12 | 3.10 | 3.29 | 5.08 | 3.51 | 4.75 | Upgrade
|
| P/OCF Ratio | 2.98 | 2.96 | 3.15 | 4.83 | 3.25 | 4.46 | Upgrade
|
| PEG Ratio | 0.92 | 0.74 | 3.00 | - | - | - | Upgrade
|
| EV/Sales Ratio | 1.10 | 1.13 | 1.16 | 1.44 | 1.17 | 1.45 | Upgrade
|
| EV/EBITDA Ratio | 3.99 | 10.26 | 10.55 | 12.56 | 4.05 | 6.80 | Upgrade
|
| EV/EBIT Ratio | 11.97 | 12.27 | 12.87 | 15.35 | 4.24 | 7.34 | Upgrade
|
| EV/FCF Ratio | 4.67 | 4.79 | 5.26 | 7.32 | 4.42 | 6.51 | Upgrade
|
| Debt / Equity Ratio | 1.69 | 1.69 | 1.74 | 1.83 | 1.13 | 3.71 | Upgrade
|
| Debt / EBITDA Ratio | 1.42 | 1.42 | 1.62 | 1.68 | 0.69 | 1.41 | Upgrade
|
| Debt / FCF Ratio | 1.67 | 1.67 | 2.02 | 2.31 | 1.00 | 2.11 | Upgrade
|
| Asset Turnover | 1.27 | 1.27 | 1.19 | 1.16 | 1.79 | 1.52 | Upgrade
|
| Inventory Turnover | 28.99 | 28.99 | 27.72 | 25.32 | 32.71 | 32.71 | Upgrade
|
| Quick Ratio | 0.44 | 0.44 | 0.52 | 0.51 | 0.53 | 0.60 | Upgrade
|
| Current Ratio | 0.56 | 0.56 | 0.64 | 0.62 | 0.64 | 0.71 | Upgrade
|
| Return on Equity (ROE) | 18.77% | 18.77% | 13.84% | 17.79% | 113.46% | 80.04% | Upgrade
|
| Return on Assets (ROA) | 7.28% | 7.28% | 6.67% | 6.75% | 30.79% | 18.82% | Upgrade
|
| Return on Capital (ROIC) | 8.96% | 8.96% | 8.01% | 8.29% | 38.89% | 23.67% | Upgrade
|
| Return on Capital Employed (ROCE) | 19.00% | 19.00% | 16.20% | 16.70% | 68.00% | 40.20% | Upgrade
|
| Earnings Yield | 5.95% | 6.00% | 4.76% | 5.17% | 19.34% | 8.80% | Upgrade
|
| FCF Yield | 32.00% | 32.28% | 30.42% | 19.70% | 28.51% | 21.04% | Upgrade
|
| Dividend Yield | 4.43% | 4.64% | 5.14% | 4.53% | 14.34% | 5.33% | Upgrade
|
| Payout Ratio | 76.92% | 76.92% | 83.35% | 269.85% | 13.59% | 69.57% | Upgrade
|
| Buyback Yield / Dilution | 4.63% | 4.63% | 0.82% | 0.18% | -32.47% | -4.65% | Upgrade
|
| Total Shareholder Return | 9.12% | 9.28% | 5.95% | 4.71% | -18.13% | 0.68% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.